These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 958545)

  • 1. [Immunosuppressive treatment of multiple sclerosis].
    Frick E
    Nervenarzt; 1976 Jul; 47(7):424-8. PubMed ID: 958545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Immunosuppressive treatment of multiple sclerosis with ALG and/or thoracic duct drainage.
    Brendel W; Ring J; Seifert J
    Neurology; 1975 May; 25(5):490. PubMed ID: 1169712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
    Frick E; Angstwurm H; Blomer R; Strauss G
    MMW Munch Med Wochenschr; 1977 Sep; 119(35):1111-4. PubMed ID: 408666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders.
    Brendel W; Seifert J; Lob G
    Proc R Soc Med; 1972 Jun; 65(6):531-5. PubMed ID: 5035906
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensive immunosuppression in the treatment of multiple sclerosis.
    Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
    Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J
    Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New treatments for multiple sclerosis.
    Hallpike JF
    Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antilymphocyte globulin in intensive immunosuppression in patients with multiple sclerosis].
    Cendrowski W
    Postepy Hig Med Dosw; 1978; 32(4):513-22. PubMed ID: 724575
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot study with antilymphocyte globulin in the treatment of multiple sclerosis.
    Ring J; Seifert J; Anstwurm H; Frick E; Mertin J; Brass B; Backmund H; Lob G
    Postgrad Med J; 1976; 52(5 Suppl):123-30. PubMed ID: 792844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man].
    Tilz GP
    Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374
    [No Abstract]   [Full Text] [Related]  

  • 13. Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro.
    Knight SC; Lance EM; Abbosh J; Munro A; O'Brien J
    Clin Exp Immunol; 1975 Jul; 21(1):23-31. PubMed ID: 1181076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Immunotherapy for multiple sclerosis.
    Br Med J; 1975 Nov; 4(5995):486-7. PubMed ID: 1192142
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Intensive immunosuppression in multiple sclerosis.
    Lance EM; Abbosh J; Kremer M; Jones V; Knight S; Medawar P
    Neurology; 1975 May; 25(5):491. PubMed ID: 1169713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chromosomal aberrations in peripheral lymphocytes of patients with multiple sclerosis (author's transl)].
    Unglaub-Leisten I; Stickl H; Frick E; Angstwurm H; Ring J
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2028-34. PubMed ID: 1157719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evidence justifying immunosuppression therapy in multiple sclerosis.
    Mertin J
    Proc R Soc Med; 1977 Dec; 70(12):871-4. PubMed ID: 202967
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple sclerosis--immunopathogenesis, traditional therapeutic strategy and suggested combined immunotherapy].
    Skotnicki AB; Aleksandrowicz J; Retinger-Grzesiuła M; Zduńczyk A; Grochmal S; Huczyński J
    Postepy Hig Med Dosw; 1983; 37(1):1-32. PubMed ID: 6356094
    [No Abstract]   [Full Text] [Related]  

  • 19. Thoracic duct drainage as an aid for immunosuppression in human renal transplantation.
    Murray JE; Birtch A; Wilson RE
    Transplant Proc; 1972 Dec; 4(4):465 passim. PubMed ID: 4566787
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.